Stocks Are Heading Lower on September 10 Ahead of The ECB
EU flag in front of Berlaymont building facade

Stocks Are Heading Lower on September 10 Ahead of The ECB

Free

Subscribe to receive this daily commentary directly in your email

Independent macro and options research, published every trading day — $85/mo or $750/yr

Subscribe →

September 10, 2020

STOCKS – REGN, GILD, VRTX

Macro – SPY, DXY

Mike’s Reading The Markets (RTM) Premium Content – NOW WITH A 2 WEEK FREE TRIAL

 

MICHAEL KRAMER AND THE CLIENTS OF MOTT CAPITAL OWN TSLA 

MICHAEL KRAMER HAS QQQ PUTS

Dollar (DXY)

Stocks are trading lower this morning ahead of the ECB rate announcement. While it isn’t likely to yield much in the way of a change in stance, it could be heavy in jawboning regarding the recent strengthening of the euro. If that is the case, then there is a good chance we see the euro weaken, as the dollar strengthens in the days and weeks ahead.

The dollar index has continued to struggle to break out at the 93.50 level, but I do feel that it is likely to change significantly if the language out of the ECB is strong enough.

Navigating The Market · By Michael Kramer

Independent macro and options research, published every trading day.

Daily written analysis covering gamma exposure, dealer flows, key levels, and the macro drivers moving markets. Includes full video access.

$85/mo or $750/year Save $270

Recent Subscriber Analysis

  • Oil, Inflation, and Policy Expectations Are Starting Come Together
  • Today's Stock Market Rally On Divergent Path...
  • A Less Market Friendly Fed Lies Ahead
  • Reading Volatility, Part 4: Event Volatility — The VIX 1-Day And The Daily Reset
  • S&P500: 7,000 Is The Level That Matters

S&P 500 (SPY)

The S&P 500 is indicated to open down about 50 bps at the moment, and the late day sell-off and failure at resistance around 3425 opens the door to a retest and move lower back 3,320, to fill that giant gap. I’m not sure if it all happens today or over the next few days, but I think in general, at this point, the mood of the market has shifted lower.

Gilead (GILD)

Gilead hasn’t been particularly strong lately, and a break of support at $63.75 is likely to send the stock to around $62. Even though the RSI is near oversold levels, I think the stock falls some more before finally bottoming out.

The Market Chronicles · Video Membership

The daily market commentary, delivered in video.

Same daily market analysis, in video form — available to YouTube channel members only.

$49.99/mo via YouTube membership

Latest Videos

Regeneron (REGN)

Regeneron has been very weak lately as well, after breaking its uptrend. It likely means that the stock is heading lower to around $515.

Vertex (VRTX)

Vertex has been very week recently, as it approaches support at $263. A break of $263 sets up a further drop to its next support at $245.

Ok, that’s all for now.

Mike

 

Mott Capital Management, LLC is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and, unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Past performance is not indicative of future results.   

This report contains independent commentary to be used for informational and educational purposes only. Michael Kramer is a member and investment adviser representative with Mott Capital Management. Mr. Kramer is not affiliated with this company and does not serve on the board of any related company that issued this stock. All opinions and analyses presented by Michael Kramer in this analysis or market report are solely Michael Kramer’s views. Readers should not treat any opinion, viewpoint, or prediction expressed by Michael Kramer as a specific solicitation or recommendation to buy or sell a particular security or follow a particular strategy. Michael Kramer’s analyses are based upon information and independent research that he considers reliable, but neither Michael Kramer nor Mott Capital Management guarantees its completeness or accuracy, and it should not be relied upon as such. Michael Kramer is not under any obligation to update or correct any information presented in his analyses. Mr. Kramer’s statements, guidance, and opinions are subject to change without notice. Past performance is not indicative of future results. Neither Michael Kramer nor Mott Capital Management guarantees any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment commentary presented in this analysis. Strategies or investments discussed may fluctuate in price or value. Investments or strategies mentioned in this analysis may not be suitable for you. This material does not consider your particular investment objectives, financial situation, or needs and is not intended as a recommendation appropriate for you. You must make an independent decision regarding investments or strategies in this analysis. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Before acting on information in this analysis, you should consider whether it is suitable for your circumstances and strongly consider seeking advice from your own financial or investment adviser to determine the suitability of any investment.